Interferon alfa-2b biosimilar (SICOR Biotech)

干扰素α-2b生物类似药（SICOR Biotech）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon alfa-2b biosimilar (SICOR Biotech)
Drug Alias Name干扰素α-2b生物仿制药（SICOR Biotech）Interferon alfa 2b (SICOR Biotech)LemeronRealdiron
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionImmunostimulantsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsMultiple MyelomaMelanomaLeukemia, Hairy Cell +[6] 
Global Approved IndicationsMultiple MyelomaMelanomaLeukemia, Hairy Cell +[6] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryMexico
Original Approved Date2001/07/01
Country/TerritoryMexico
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTeva
China Registration ClassN/A

Develop Information

Active CompaniesTeva Pharmaceutical Industries Ltd
Inactive CompaniesN/A
Active IndicationsMultiple MyelomaMelanomaLeukemia, Hairy Cell +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeL03AB05
Related LinksN/A